Abstract P6-18-01: Treatment benefit of ribociclib + letrozole in patients with de novo disease and visceral metastases from the MONALEESA-2 study
O'Shaughnessy, JA, Arteaga, CL, Hart, LL, Lindquist, DL, Beck, JT, Purkayastha, DD, Caria, N, Hortobagyi, GN
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial
ROTHENBERG, Mace L, OZA, Amit M, LE BAIL, Nathalie, HALLER, Daniel G, BIGELOW, Robert H, BERLIN, Jordan D, MARSHALL, John L, RAMANATHAN, Ramesh K, HART, Lowell L, GUPTA, Sunil, GARAY, Carlos A, BURGER, Brent G
Published in Journal of clinical oncology (01.06.2003)
Published in Journal of clinical oncology (01.06.2003)
Get full text
Journal Article
Abstract PD4-06: First-line ribociclib + letrozole in hormone receptor-positive, HER2-negative advanced breast cancer: Efficacy by baseline circulating tumor DNA alterations in MONALEESA-2
Hortobagyi, GN, Stemmer, S, Campone, M, Sonke, GS, Arteaga, CL, Paluch-Shimon, S, Petrakova, K, Villanueva, C, Nusch, A, Grischke, E-M, Chan, A, Jakobsen, E, Marschner, N, Hart, LL, Alba, E, Ohnstand, HO, Blau, S, Yardley, DA, Solovieff, N, Su, F, Germa, C, Yap, Y-S
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Abstract P4-22-05: First-line ribociclib plus letrozole in patients with de novo HR+, HER2– advanced breast cancer (ABC): A subgroup analysis of the MONALEESA-2 trial
O'Shaughnessy, J, Petrakova, K, Sonke, GS, André, F, Conte, P, Arteaga, CL, Cameron, DA, Hart, LL, Villanueva, C, Jakobsen, EH, Lindquist, D, Souami, F, Li, X, Germa, C, Hirawat, S, Hortobagyi, GN
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P1-01-01: Circulating tumor cell number and CTC-endocrine therapy index predict clinical outcomes in ER positive metastatic breast cancer patients: Results of the COMETI Phase 2 trial
Paoletti, C, Regan, MM, Liu, MC, Marcom, PK, Hart, LL, Smith, JW, Tedesco, KL, Amir, E, Krop, IE, DeMichele, AM, Goodwin, PJ, Block, M, Aung, K, Cannell, EM, Darga, EP, Baratta, PJ, Brown, ME, McCormack, RT, Hayes, DF
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract OT1-1-13: A phase II study with lead-in safety cohort of cabazitaxel plus lapatinib as therapy for patients with HER2-positive metastatic breast cancer (MBC) and intracranial metastases
Yardley, DA, Hainsworth, JD, Hamilton, E, Hart, LL, Shastry, M, Finney, L, Burris, HA
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
Abstract P4-16-04: Amrubicin as second- or third-line treatment for patients with HER2-negative metastatic breast cancer (MBC): Final results from a phase II trial of the Sarah Cannon Research Institute (SCRI)
Yardley, DA, Barton, J, Raefsky, E, Harwin, W, Priego, V, Inclan, A, Miletello, G, Hart, LL, Shastry, M, Finney, L, Hainsworth, JD, Burris, HA
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy
Burton, Gary V., Hart, Lowell L., Leight, George S., Iglehart, James D., McCarty, Kenneth S., Cox, Edwin B.
Published in Cancer (01.06.1989)
Published in Cancer (01.06.1989)
Get full text
Journal Article